Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.

IF 7 2区 医学 Q1 ONCOLOGY Chinese Journal of Cancer Research Pub Date : 2023-10-30 DOI:10.21147/j.issn.1000-9604.2023.05.10
Yunfei Shi, Haojie Wang, Yanfei Liu, Mengping Long, Ning Ding, Lan Mi, Yumei Lai, Lixin Zhou, Xinting Diao, Xianghong Li, Weiping Liu, Jun Zhu
{"title":"Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.","authors":"Yunfei Shi, Haojie Wang, Yanfei Liu, Mengping Long, Ning Ding, Lan Mi, Yumei Lai, Lixin Zhou, Xinting Diao, Xianghong Li, Weiping Liu, Jun Zhu","doi":"10.21147/j.issn.1000-9604.2023.05.10","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the application of genetic abnormalities in the diagnosis of angioimmunoblastic T-cell lymphoma (AITL) and the reliable pathological prognostic factors.</p><p><strong>Methods: </strong>This study included 53 AITL cases, which were reviewed for morphological patterns, immunophenotypes, presence of Hodgkin and Reed-Sternberg (HRS)-like cells, and co-occurrence of B cell proliferation. The Epstein-Barr virus (EBV)-positive cells in tissues were counted, and cases were classified into \"EBV encoded RNA (EBER) high-density\" group if >50/HPF. Targeted exome sequencing was performed.</p><p><strong>Results: </strong>Mutation data can assist AITL diagnosis: 1) with considerable HRS-like cells (20 cases): <i>RHOA</i> mutated in 14 cases (<i>IDH2</i> co-mutated in 3 cases, 4 cases with rare <i>RHOA</i> mutation), <i>TET2</i> was mutated in 5 cases (1 case co-mutated with <i>DNMT3A</i>), and <i>DNMT3A</i> mutated in 1 case; 2) accompanied with B cell lymphoma (7 cases): <i>RHOA</i> mutated in 4 cases (1 case had <i>IDH2</i> mutation), <i>TET2</i> mutated in 2 cases and <i>DNMT3A</i> mutated in 1 case; 3) mimic peripheral T cell lymphoma, not otherwise specified (5 cases): <i>RHOA</i> mutated in 2 cases (<i>IDH2</i> co-mutated in 1 case), <i>TET2</i> mutated in 3 cases, and <i>DNMT3A</i> mutated in 1 case; 4) pattern 1 (1 case), <i>RHOA</i> and <i>TET2</i> co-mutated. Besides <i>RHOA</i><sup>G17V</sup> (30/35), rare variant included <i>RHOA</i><sup>K18N</sup>, <i>RHOA</i><sup>R68H</sup>, <i>RHOA</i><sup>C83Y</sup>, <i>RHOA</i><sup>D120G</sup> and <i>RHOA</i><sup>G17del</sup>, <i>IDH2</i><sup>R172</sup> co-mutated with <i>IDH2</i><sup>M397V</sup> in one case. There were recurrent mutations of <i>FAT3</i>, <i>PCLO</i> and <i>PIEZO1</i> and genes of epigenetic remodeling, T-cell activation, APC and PI3K/AKT pathway. EBER high-density independently indicated adverse overall survival and progression-free survival (P=0.046 and P=0.008, Kaplan-Meier/log-rank).</p><p><strong>Conclusions: </strong>Over half AITL cases might be confused in diagnosis for certain conditions without mutation data. Targeted exome sequencing with a comprehensive panel is crucial to detect both hot-spot and rare mutation variants for <i>RHOA</i> and <i>IDH2</i> and other recurrent mutated genes in addition to <i>TET2</i> and <i>DNMT3A</i>. EBER high-density independently indicated adverse survival.</p>","PeriodicalId":9882,"journal":{"name":"Chinese Journal of Cancer Research","volume":null,"pages":null},"PeriodicalIF":7.0000,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643336/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21147/j.issn.1000-9604.2023.05.10","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the application of genetic abnormalities in the diagnosis of angioimmunoblastic T-cell lymphoma (AITL) and the reliable pathological prognostic factors.

Methods: This study included 53 AITL cases, which were reviewed for morphological patterns, immunophenotypes, presence of Hodgkin and Reed-Sternberg (HRS)-like cells, and co-occurrence of B cell proliferation. The Epstein-Barr virus (EBV)-positive cells in tissues were counted, and cases were classified into "EBV encoded RNA (EBER) high-density" group if >50/HPF. Targeted exome sequencing was performed.

Results: Mutation data can assist AITL diagnosis: 1) with considerable HRS-like cells (20 cases): RHOA mutated in 14 cases (IDH2 co-mutated in 3 cases, 4 cases with rare RHOA mutation), TET2 was mutated in 5 cases (1 case co-mutated with DNMT3A), and DNMT3A mutated in 1 case; 2) accompanied with B cell lymphoma (7 cases): RHOA mutated in 4 cases (1 case had IDH2 mutation), TET2 mutated in 2 cases and DNMT3A mutated in 1 case; 3) mimic peripheral T cell lymphoma, not otherwise specified (5 cases): RHOA mutated in 2 cases (IDH2 co-mutated in 1 case), TET2 mutated in 3 cases, and DNMT3A mutated in 1 case; 4) pattern 1 (1 case), RHOA and TET2 co-mutated. Besides RHOAG17V (30/35), rare variant included RHOAK18N, RHOAR68H, RHOAC83Y, RHOAD120G and RHOAG17del, IDH2R172 co-mutated with IDH2M397V in one case. There were recurrent mutations of FAT3, PCLO and PIEZO1 and genes of epigenetic remodeling, T-cell activation, APC and PI3K/AKT pathway. EBER high-density independently indicated adverse overall survival and progression-free survival (P=0.046 and P=0.008, Kaplan-Meier/log-rank).

Conclusions: Over half AITL cases might be confused in diagnosis for certain conditions without mutation data. Targeted exome sequencing with a comprehensive panel is crucial to detect both hot-spot and rare mutation variants for RHOA and IDH2 and other recurrent mutated genes in addition to TET2 and DNMT3A. EBER high-density independently indicated adverse survival.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
遗传异常有助于病理诊断,ebv阳性细胞密度影响中国血管免疫母细胞淋巴瘤患者的生存。
目的:探讨遗传异常在血管免疫母细胞性t细胞淋巴瘤(AITL)诊断中的应用及可靠的病理预后因素。方法:对53例AITL患者的形态学、免疫表型、HRS样细胞的存在及B细胞增殖的共现情况进行回顾性分析。统计组织中eb病毒(EBV)阳性细胞数,将>50/HPF归为“EBV编码RNA (EBER)高密度”组。进行靶向外显子组测序。结果:突变资料可辅助AITL诊断:1)有相当数量的hrs样细胞(20例):RHOA突变14例(IDH2共突变3例,RHOA罕见突变4例),TET2突变5例(与DNMT3A共突变1例),DNMT3A突变1例;2)伴有B细胞淋巴瘤(7例):RHOA突变4例(1例伴有IDH2突变),TET2突变2例,DNMT3A突变1例;3)模拟外周T细胞淋巴瘤,无其他特异性(5例):RHOA突变2例(IDH2共突变1例),TET2突变3例,DNMT3A突变1例;4)模式1(1例),RHOA与TET2共突变。除RHOAG17V(30/35)外,罕见变异包括RHOAK18N、RHOAR68H、RHOAC83Y、RHOAD120G和RHOAG17del, IDH2R172与IDH2M397V共突变1例。FAT3、PCLO、PIEZO1及表观遗传重塑、t细胞活化、APC、PI3K/AKT通路基因反复突变。EBER高密度独立显示不良的总生存期和无进展生存期(P=0.046和P=0.008, Kaplan-Meier/log-rank)。结论:超过半数的AITL病例在没有突变数据的情况下可能会对某些情况的诊断产生混淆。综合面板的靶向外显子组测序对于检测RHOA和IDH2以及除TET2和DNMT3A外的其他复发突变基因的热点和罕见突变变体至关重要。EBER高密度独立提示生存不良。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
9.80%
发文量
1726
审稿时长
4.5 months
期刊介绍: Chinese Journal of Cancer Research (CJCR; Print ISSN: 1000-9604; Online ISSN:1993-0631) is published by AME Publishing Company in association with Chinese Anti-Cancer Association.It was launched in March 1995 as a quarterly publication and is now published bi-monthly since February 2013. CJCR is published bi-monthly in English, and is an international journal devoted to the life sciences and medical sciences. It publishes peer-reviewed original articles of basic investigations and clinical observations, reviews and brief communications providing a forum for the recent experimental and clinical advances in cancer research. This journal is indexed in Science Citation Index Expanded (SCIE), PubMed/PubMed Central (PMC), Scopus, SciSearch, Chemistry Abstracts (CA), the Excerpta Medica/EMBASE, Chinainfo, CNKI, CSCI, etc.
期刊最新文献
Efficacy and safety of dacomitinib as first-line treatment for advanced non-small cell lung cancer patients with epidermal growth factor receptor 21L858R mutation: A multicenter, case-series study in China. Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors. Potential value of detection of minimal residual disease in colorectal cancer following radical resection. Tumor-derived DEFB1 induces immune tolerance by inhibiting maturation of dendritic cell and impairing CD8+ T cell function in esophageal squamous cell carcinoma. SOX11 as a potential prognostic biomarker in hepatocellular carcinoma linked to immune infiltration and ferroptosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1